# Quell Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/quell-therapeutics

- Industry: Biotechnology
- Headquarters: London, UK
- Website: www.quell-tx.com
- Total disclosed funding: $202M
- Latest round: Series B (Nov 29, 2021)
- Investors on record: 11

## About

Based in London, UK, and founded in 2019, Quell Therapeutics Ltd. provides regulatory T cells (Treg) therapies as immunosuppression for patients recovering from a liver transplant. The company was co-founded by Giovanna Lombardi, Marc Martinez-Llordella, Alberto Sánchez-Fueyo, Hans Stauss, Emma Morris, and Elmar Jaeckel. In 2019 and 2021, Quell Therapeutics Ltd. raised funding from Albion Capital and Syncona Limited.

Quell Therapeutics Ltd. works with pharmaceutical companies, by offering the regulatory T cells (Treg) therapies for immune dysregulations, such as autoimmunity, inflammatory conditions, and solid organ transplantation, for patients recovering from a liver transplant. Therapies will enable patients to live with transplanted liver without taking immunosuppressive medication. The company will offer the therapy under the research & preclinical development phase for future commercialization.

The company generates revenue by selling the therapies for immunosuppression to pharmaceutical companies.

Quell Therapeutics Ltd.’s future strategy includes further research and preclinical development of immunosuppression therapies and expanding the senior leadership team.

## Funding rounds

- Series B, Nov 29, 2021, $156M — SV Health Investors, Tekla Capital Management, Fidelity Investments, Syncona, Monashee Investment Management, Janus Henderson Investors, Point72 Asset Management, Ridgeback Asset Management, British Patient Capital, Jeito Capital
- Series A, Dec 4, 2020, $35M — Albion Capital, Syncona
- Series A, Mar 29, 2019, $11M — Albion Capital, Syncona

## Investors

- Albion Capital — Series A
- Syncona (https://capitalatlas.ai/funds/syncona) — Series A, Series B
- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Series B
- Tekla Capital Management (https://capitalatlas.ai/funds/tekla-capital-management) — Series B
- Fidelity Investments (https://capitalatlas.ai/funds/fidelity-investments) — Series B
- Monashee Investment Management — Series B
- Janus Henderson Investors — Series B
- Point72 Asset Management — Series B
- Ridgeback Asset Management — Series B
- British Patient Capital — Series B
- Jeito Capital (https://capitalatlas.ai/funds/jeito-capital) — Series B